—

DAFNA Capital Management LLC

Q4 2025 13F Holdings

  • Location
    los angeles, CA
  • Num holdings

    77

  • Value ($000)

    $430,519

  • Date Filed
    02/17/2026
  • Form type
    13F-HR
  • CIK
    0001389933
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q4 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
R
RVMD

REVOLUTION MEDICINES INC

COM
76155X100
$48.15M
11 %

604,514

K
KRE

SPDR S&P BIOTECH ETF

ETF
78464A870
$41.03M
10 %

336,505

R
RJR1

STEREOTAXIS INC

COM NEW
85916J409
$31.47M
7 %

13,680,554

A
ATRC

ATRICURE INC

COM
04963C209
$23.63M
6 %

597,431

C
CYTK

CYTOKINETICS INC

COM NEW
23282W605
$23.57M
6 %

370,997

I
IDYA

IDEAYA BIOSCIENCES INC

COM
45166A102
$17.52M
4 %

506,740

A
AXGN

AXOGEN INC

COM
05463X106
$15.61M
4 %

476,826

---

XENON PHARMACEUTICALS INC

COM
98420N105
$12.91M
3 %

287,939

I
IBB

ISHARES NASDAQ BIOTECH INDX

ETF
464287556
$11.49M
3 %

68,095

---

BIOHAVEN LTD

COM
G1110E107
$10.78M
3 %

955,235

Rows Per Page
10
  • 5
  • 10
  • 20
  • 30
  • 50
  • 100
1 - 10 of 77